Document is current
Any future updates will be listed below
-
Authors
Lin, Sherry https://orcid.org/0000-0002-1275-8391
Gillis, Winthrop F.
Weinreb, Caleb
Zeine, Ayman
Jones, Samuel C.
Robinson, Emma M. https://orcid.org/0000-0003-2982-3142
Markowitz, Jeffrey
Datta, Sandeep Robert https://orcid.org/0000-0002-8068-3862
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U24NS109520, U19NS113201, R01NS114020, RF1AG073625)
- License Information
-
More Information
Article History
Received: 5 October 2022
Accepted: 12 April 2024
First Online: 26 June 2024
Competing interests
: S.R.D. sits on the scientific advisory boards of Neumora, Inc. and Gilgamesh Therapeutics, which have licensed the MoSeq technology.
